[96a5a0]: / output / allTrials / identified / NCT00004176_identified.json

Download this file

420 lines (420 with data), 20.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
{
"info": {
"nct_id": "NCT00004176",
"official_title": "A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Histologically confirmed limited stage small cell lung cancer confined to one hemithorax Measurable disease No pleural effusion(s)\n\nPATIENT CHARACTERISTICS: Age: 18 and over Performance status: Karnofsky 60-100% Life expectancy: Not specified Hematopoietic: Neutrophil count at least 1,500/mm3 Platelet count at least 75,000/mm3 Hepatic: Bilirubin no greater than 2.0 mg/dL SGOT and alkaline phosphatase no greater than 2 times upper limit of normal Renal: Creatinine no greater than 1.5 mg/dL OR Creatinine clearance at least 60 mL/min Calcium normal (8.9-10.3 mg/dL) Cardiovascular: No history of congestive heart failure or myocardial infarction within the past 6 months No uncontrolled or unexplained rhythm disturbance or symptoms of unstable ischemic heart disease Other: Not pregnant Fertile patients must use effective contraception No prior or concurrent malignancy within the past 5 years, except: Basal or squamous cell skin cancer Carcinoma in situ of the cervix No concurrent infection No significant uncontrolled hyponatremia No other significant concurrent medical or psychiatric illness which would preclude compliance No antecedent hearing loss Afebrile for at least 3 days unless fever due to tumor or obstructive pneumonia\n\nPRIOR CONCURRENT THERAPY: Biologic therapy: No prior biologic therapy Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy Surgery: Not specified Other: No drugs that could potentiate nephrotoxicity of cisplatin (e.g., aminoglycosides or lithium)"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS: Histologically confirmed limited stage small cell lung cancer confined to one hemithorax Measurable disease No pleural effusion(s)",
"criterions": [
{
"exact_snippets": "Histologically confirmed limited stage small cell lung cancer",
"criterion": "small cell lung cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "limited"
},
{
"requirement_type": "confirmation",
"expected_value": "histologically"
}
]
},
{
"exact_snippets": "confined to one hemithorax",
"criterion": "cancer location",
"requirements": [
{
"requirement_type": "location",
"expected_value": "one hemithorax"
}
]
},
{
"exact_snippets": "Measurable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": true
}
]
},
{
"exact_snippets": "No pleural effusion(s)",
"criterion": "pleural effusion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Karnofsky 60-100% Life expectancy: Not specified Hematopoietic: Neutrophil count at least 1,500/mm3 Platelet count at least 75,000/mm3 Hepatic: Bilirubin no greater than 2.0 mg/dL SGOT and alkaline phosphatase no greater than 2 times upper limit of normal Renal: Creatinine no greater than 1.5 mg/dL OR Creatinine clearance at least 60 mL/min Calcium normal (8.9-10.3 mg/dL) Cardiovascular: No history of congestive heart failure or myocardial infarction within the past 6 months No uncontrolled or unexplained rhythm disturbance or symptoms of unstable ischemic heart disease Other: Not pregnant Fertile patients must use effective contraception No prior or concurrent malignancy within the past 5 years, except: Basal or squamous cell skin cancer Carcinoma in situ of the cervix No concurrent infection No significant uncontrolled hyponatremia No other significant concurrent medical or psychiatric illness which would preclude compliance No antecedent hearing loss Afebrile for at least 3 days unless fever due to tumor or obstructive pneumonia",
"criterions": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Performance status: Karnofsky 60-100%",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 60,
"unit": "%"
},
{
"operator": "<=",
"value": 100,
"unit": "%"
}
]
}
}
]
},
{
"exact_snippets": "Life expectancy: Not specified",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "specification",
"expected_value": "not specified"
}
]
},
{
"exact_snippets": "Hematopoietic: Neutrophil count at least 1,500/mm3",
"criterion": "neutrophil count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Platelet count at least 75,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 75000,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Hepatic: Bilirubin no greater than 2.0 mg/dL",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 2.0,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "SGOT and alkaline phosphatase no greater than 2 times upper limit of normal",
"criterion": "SGOT and alkaline phosphatase levels",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": "no greater than 2 times upper limit of normal"
}
]
},
{
"exact_snippets": "Renal: Creatinine no greater than 1.5 mg/dL",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "Creatinine clearance at least 60 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min"
}
}
]
},
{
"exact_snippets": "Calcium normal (8.9-10.3 mg/dL)",
"criterion": "calcium level",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 8.9,
"unit": "mg/dL"
},
{
"operator": "<=",
"value": 10.3,
"unit": "mg/dL"
}
]
}
}
]
},
{
"exact_snippets": "Cardiovascular: No history of congestive heart failure or myocardial infarction within the past 6 months",
"criterion": "history of congestive heart failure or myocardial infarction",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "No uncontrolled or unexplained rhythm disturbance or symptoms of unstable ischemic heart disease",
"criterion": "uncontrolled or unexplained rhythm disturbance or symptoms of unstable ischemic heart disease",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "Other: Not pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "Fertile patients must use effective contraception",
"criterion": "contraception use in fertile patients",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
},
{
"exact_snippets": "No prior or concurrent malignancy within the past 5 years, except: Basal or squamous cell skin cancer Carcinoma in situ of the cervix",
"criterion": "prior or concurrent malignancy within the past 5 years",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "No concurrent infection",
"criterion": "concurrent infection",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "No significant uncontrolled hyponatremia",
"criterion": "significant uncontrolled hyponatremia",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "No other significant concurrent medical or psychiatric illness which would preclude compliance",
"criterion": "significant concurrent medical or psychiatric illness",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "No antecedent hearing loss",
"criterion": "antecedent hearing loss",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "Afebrile for at least 3 days unless fever due to tumor or obstructive pneumonia",
"criterion": "afebrile status",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "at least 3 days"
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY: Biologic therapy: No prior biologic therapy Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy Surgery: Not specified Other: No drugs that could potentiate nephrotoxicity of cisplatin (e.g., aminoglycosides or lithium)",
"criterions": [
{
"exact_snippets": "No prior biologic therapy",
"criterion": "prior biologic therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Not specified",
"criterion": "prior endocrine therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "not specified"
}
]
},
{
"exact_snippets": "No prior radiotherapy",
"criterion": "prior radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Not specified",
"criterion": "prior surgery",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "not specified"
}
]
},
{
"exact_snippets": "No drugs that could potentiate nephrotoxicity of cisplatin (e.g., aminoglycosides or lithium)",
"criterion": "drugs that could potentiate nephrotoxicity of cisplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}